Front Row Advisors LLC Abbott Laboratories Transaction History

Front Row Advisors LLC

$271 Million
Q3 2024

A detailed history of Front Row Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Front Row Advisors LLC holds 390 shares of ABT stock, worth $44,549. This represents 0.02% of its overall portfolio holdings.

Number of Shares

390

Previous 785 50.32%

Holding current value

$44,549

Previous $81,000 45.68%

% of portfolio

0.02%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $39,527 - $46,661	-395 Reduced 50.32%	390 $44,000
Q2 2024 Aug 15, 2024	SELL	$100.73 - $112.44 $201 - $224	-2 Reduced 0.25%	785 $81,000
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $43,479 - $48,021	397 Added 101.79%	787 $89,000
Q4 2023 Feb 15, 2024	SELL	$90.19 - $110.4 $18,398 - $22,521	-204 Reduced 34.34%	390 $42,000
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $7,260 - $8,711	-76 Reduced 11.34%	594 $57,000
Q1 2023 May 22, 2023	BUY	$96.86 - $114.01 $58,309 - $68,634	602 Added 885.29%	670 $68,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $14,044 - $16,531	-145 Reduced 68.08%	68 $67,000
Q4 2022 Feb 15, 2023	SELL	$95.06 - $111.52 $33,461 - $39,255	-352 Reduced 62.3%	213 $23,000
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.18%	565 $55,000
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $13,167 - $15,914	-129 Reduced 18.61%	564 $61,000
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $114 - $139	1 Added 0.14%	693 $82,000
Q4 2021 Mar 09, 2022	BUY	$115.53 - $141.46 $115 - $141	1 Added 0.14%	692 $97,000
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $1,166 - $1,290	-10 Reduced 1.43%	691 $82,000
Q2 2021 Aug 23, 2021	SELL	$105.79 - $124.53 $211 - $249	-2 Reduced 0.28%	701 $88,000
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $8,816 - $10,386	81 Added 13.02%	703 $84,000
Q3 2020 Nov 30, 2020	SELL	$91.64 - $111.29 $8,430 - $10,238	-92 Reduced 12.89%	622 $67,000
Q2 2020 Aug 17, 2020	SELL	$76.57 - $98.0 $1,531 - $1,960	-20 Reduced 2.72%	714 $65,000
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $9,611 - $14,054	153 Added 26.33%	734 $68,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $14,602 - $16,256	186 Added 47.09%	581 $51,000
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $81 - $88	1 Added 0.25%	395 $33,000
Q2 2019 Aug 27, 2019	BUY	$72.88 - $85.0 $145 - $170	2 Added 0.51%	394 $33,000
Q1 2019 May 17, 2019	BUY	$66.22 - $80.06 $23,044 - $27,860	348 Added 790.91%	392 $31,000
Q4 2017 Feb 01, 2018	BUY	$53.68 - $57.47 $2,361 - $2,528	44	44 $3,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account

Front Row Advisors LLC Abbott Laboratories Transaction History